HCW Biologics (HCWB) Live Share Price, Invest From India

HCW Biologics Stock Performance

as on August 26, 2026 at 6:59 am IST

Day's Low
Day's High
$2.28
Day's Price Range
$2.85
$2.54
10.24%
Downside
12.20%
Upside
52 Week's Low
52 Week's High
$1.50
52-Week Price Range
$44.10
$2.54
40.94%
Downside
1636.22%
Upside

HCW Biologics share price movements today

Previous Close: $2.31
Open: $2.28
Volume: 456.1K
Market Cap: $4.3M
Day's Low - High: $2.28 - $2.85
52 Week Low - High: $1.50 - $44.10

HCW Biologics Historical Returns

1 Month Return: -33 %
3 Month Return: -63.39 %
1 Year Return: -89.08 %
3 Year Return: -99.45 %
5 Year Return: -99.78 %

HCW Biologics Stock Fundamentals & Key Indicators

Check HCW Biologics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.3M

EPS (TTM)

-2.88

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-5.7M

Revenue (TTM)

6.6M

Profit Margin

-34.74%

Return On Equity TTM

-27725.96%

HCW Biologics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of HCW Biologics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
HCW Biologics	BUY	$4.3M	-99.78%	NA	-34.74%	NA
Revolution Medicines	BUY	$43.7B	669.3%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$128.2B	154.86%	29.82	86.04%	NA
Moderna	BUY	$25.3B	-84.24%	-7.98	-12.57%	NA
Regeneron	BUY	$82.7B	24.1%	19.24	84.86%	0.44999999999999996%

Stock Returns calculator for HCW Biologics Stock including INR - Dollar returns

The HCW Biologics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

HCW Biologics investment value today

Current value as on today

₹11,272

Returns

-₹88,728

(-88.73%)

Returns from HCW Biologics Stock

-₹89,650 (-89.65%)

Dollar Impact

₹922 (+0.92%)

Analyst Recommendation on HCW Biologics Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for HCW Biologics. Average target price of $30

HCW Biologics Share Price Target

Get share price movements and forecasts by analysts on HCW Biologics.

What analysts predicted

91.53%UPSIDE

Target Price

$30

Current Price

$2.54

Analyzed by

1 Analysts

Target

$30.00

HCW Biologics target price $30, a slight upside of 91.53% compared to current price of $2.54. According to 1 analysts rating.

Indian Investors' Interest in HCW Biologics Stock

Search interest for HCW Biologics Stock has decreased by -12% in the last 30 days, reflecting a downward trend in search activity.

Time period: July 27, 2026 to August 26, 2026

Change:-12% versus previous 30 day period

HCW Biologics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	1	0	0	0	0	0	0	0	6	0
Gross Profit	0	0	0	0	0	0	0	0	6	0
Operating Income	-7	-15	-3	-3	-1	-3	-3	-2	3	-3
EBITDA	-7	-14	-3	-1	-1	-1	-4	1	3	-3
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	-
Income Before Tax	-7	-15	-3	-3	-2	-1	-4	0	3	-5
Income Tax Expense	0	0	-	-	-	-	-	-	0	10
Net Income	-7	-15	-3	-3	-2	-1	-4	0	4	-15
Net Profit Margin	-662.82%	-2469.11%	-915.12%	-854.42%	-43373.64%	-29430.99%	-29183.24%	2662.84%	63.16%	-11340.34%

HCW Biologics Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	4	4	6	2	2	0
Gross Profit	0	4	0	2	0	0	0
Operating Income	-7	-5	-13	-15	-25	-29	-11
EBITDA	-6	-5	-12	-14	-23	-27	-5
Interest Expense	-	-	0	0	0	1	1
Depreciation	0	0	0	0	1	1	1
Income Before Tax	-7	-5	-12	-14	-24	-30	-7
Income Tax Expense	0	0	0	0	0	-	-
Net Income	-7	-5	-12	-14	-24	-30	-7
Net Profit Margin	0.00%	-140.98%	-313.74%	-221.67%	-879.52%	-1169.70%	-14677.14%

HCW Biologics Quarterly Cash Flow

All numbers in Millions USD

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-15	-3	-3	-2	-1	-4	0	3	-5
Operating Cash Flow	-4	-2	-2	-3	-3	-3	-3	-1	-3
Investing Cash Flow	0	0	0	-	-	-	-	-	-
Financing Cash Flow	1	2	6	0	4	1	4	0	3
Change in Cash	-2	0	3	-3	1	-1	0	0	0

HCW Biologics Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-5	-12	-14	-24	-30	-7
Operating Cash Flow	-10	-10	-10	-22	-14	-13
Investing Cash Flow	0	-35	14	3	0	-
Financing Cash Flow	11	49	6	0	15	10
Change in Cash	1	3	10	-18	1	-2

Mutual Funds that own HCW Biologics Stock

Check out the Mutual Funds with significant holdings in HCW Biologics.

Funds	Holdings	Shares Held
Fidelity Concord Street Trust	0.801954%	12806
VANGUARD INDEX FUNDS	0.75292%	12023

Global Institutional Holdings in HCW Biologics

Funds	Holdings
Vanguard	0.13%

Insights on HCW Biologics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, HCWB stock has moved up by 8.5%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 493.2% return, outperforming this stock by 586.3%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 538.4% return, outperforming this stock by 637.9%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 4.13M → -5.21M (in $), with an average decrease of 226.3% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 6.54M → 135.56K (in $), with an average decrease of 97.9% per quarter

About HCW Biologics

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States. Its lead products include HCW11-018b, a novel, tetra-valent T-Cell engager; HCW11-040, a multifunctional fusion molecule that is a combination of cytokines and pembrolizumab; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in clinical trial in patients with alopecia areata diseases. The company also develops HCW9201, a fusion protein designed as a reagent to use in the production of natural killer (NK) cell-based therapies; HCW9206, a fusion protein designed as a reagent to use in the production of CAR-therapies for the treatment of infectious diseases; and HCW11-006, a multi-functional immune cell stimulator. It has a license agreement with Wugen Inc. to develop cell therapy-based treatments; and a license, research and co-development agreement with WY Biotech Co., Ltd. for its preclinical molecule. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida.

Organisation	HCW Biologics
Headquarters	2929 North Commerce Parkway, Miramar, FL, United States, 33025
Industry	Biotechnology
CEO	Dr. Hing C. Wong Ph.D.
E-voting on shares	Click here to vote

Key Management of HCW Biologics

Name	Title
Dr. Hing C. Wong Ph.D.	Founder, CEO, Director & Secretary
Ms. Rebecca Byam CPA, M.B.A.	Chief Financial Officer
Dr. Peter Rhode Ph.D.	Chief Scientific Officer & VP of Clinical Operations
Ms. Nicole Valdivieso Esq., J.D.	Vice President of Legal Affairs
Mr. Lee D. Flowers	Senior Vice President of Business Development

FAQs

What is HCW Biologics share price today?

HCW Biologics share price today is $2.54 as on August 26, 2026 at 1:29 am IST at the close of the market. HCW Biologics share today touched a day high of $2.85 and a low of $2.28.

What is the 52 week high and 52 week low for HCW Biologics share?

HCW Biologics share touched a 52 week high of $44.10 on August 25, 2025 and a 52 week low of $1.50 on April 2, 2026. HCW Biologics stock price today i.e. August 26, 2026 at 1:29 am IST is closed at $2.54,which is 94.24% down from its 52 week high and 69.33% up from its 52 week low.

What is HCW Biologics's market capitalisation today?

HCW Biologics market capitalisation is $0.00T as on August 26, 2026 at 1:29 am IST.

How to invest in HCW Biologics Stock (HCWB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for HCW Biologics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in HCW Biologics Shares that will get you 0.5906 shares as per HCW Biologics share price of $2.54 per share as on August 26, 2026 at 1:29 am IST.

What is the minimum amount required to buy HCW Biologics Stock (HCWB) from India?

Indian investors can start investing in HCW Biologics (HCWB) shares with as little as ₹95.41 or $1 (as of August 26, 2026 at 4:47 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹954.10 in HCW Biologics stock (as per the Rupee-Dollar exchange rate as on August 26, 2026 at 4:47 am IST). Based on HCW Biologics share’s latest price of $2.54 as on August 26, 2026 at 1:29 am IST, you will get 3.9370 shares of HCW Biologics. Learn more about fractional shares .

What are the returns that HCW Biologics has given to Indian investors in the last 5 years?

HCW Biologics stock has given -99.78% share price returns and 29.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?